EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of sts 557 17 alpha cyano methyl 17 beta hydroxy estra 4 9 10 dien 3 one as a post coital contraceptive in the baboon papio cynocephalus


Contraception 23(3): 335-339
Evaluation of sts 557 17 alpha cyano methyl 17 beta hydroxy estra 4 9 10 dien 3 one as a post coital contraceptive in the baboon papio cynocephalus
A postcoital interceptive action of STS-557 [17.alpha.-cyanomethyl-17.beta.-hydroxyestra-4,9(10)-diene-3-one], a synthetic progestin, was reported in the mouse, rat and baboon. The effects in the baboon were reinvestigated with a modification of the original protocol: prolongation of the mating period from 6-48 h. The time of mating was determined by observation of the perineal sex skin and the pattern of plasma estradiol in the periovulatory period. STS-557 (0.4 mg) was administered 6 h after the initiation of mating, which was continued for an additional 42 h. Controls received an empty gelatin capsule in the same mating protocol. Conception rate in the control baboons (n = 20) was 25%; in the STS-557-treated baboons (n = 18) it was 22%. There was also no difference in the pattern of plasma estradiol and progesterone in control vs. treated baboons, either in pregnant or in nonpregnant animals. All pregnancies were normal. In light of the earlier report of effective postcoital action in the baboon from a single administration of STS-557 after a breeding period limited to 6 h, the effect of a single dose apparently is brief, and may not be clinically useful.


Accession: 005401968



Related references

Further report on the interceptive sts 557 17 alpha cyano methyl 17 beta hydroxy estra 4 9 10 dien 3 one in baboons papio hamadryas. Endokrinologie 79(3): 428-430, 1982

Further report on the endocrinological profile of 17 alpha cyano methyl 17 beta hydroxy estra 4 9 10 dien 3 one sts 557 in rodents. Endokrinologie 79(2): 173-184, 1982

Fertilizing ability of spermatozoa of rats treated with sts 557 17 alpha cyano methyl 17 beta hydroxy estra 4 9 10 dien 3 one. Archives of Andrology 11(2): 157-160, 1983

Steroids 59. tritium labeling of a new highly active gestagen sts 557 tritium labeled 17 alpha cyano methyl 17 beta hydroxy estra 4 9 dien 3 one. Journal of Labelled Compounds and Radiopharmaceuticals 17(3): 317-330, 1980

Sts 557 17 beta cyano methyl 17 beta hydroxy estra 4 9 10 dien 3 one as an interceptive in rodents and baboons. Contraception 21(5): 537-550, 1980

Effects of levo norgestrel and sts 557 17 alpha cyano methyl 17 alpha hydroxy estra 4 9 10 dien 3 one on testis in rodents. Endokrinologie 76(1): 13-22, 1980

The effect of a single midcycle administration of 0.5 or 2.0 mg dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9-dien-3-one) on pituitary and ovarian function--investigation for the use as a postcoital contraceptive. Experimental and Clinical Endocrinology 84(3): 299-304, 1984

Post coital interception by an anti progestational compound ru 486 17 beta hydroxy 11 beta 4 dimethylaminophenyl 17 alpha 1 propynylestra 4 9 dien 3 one. Archives of Gynecology 237(SUPPL): 60-61, 1985

Further studies of steroidal inhibitors of enz delta 5 3beta hydroxy steroid dehydrogenase and enz delta 5 delta 4 3 keto steroid isomerase in pseudomonas testosteroni and in bovine adrenals 2 alpha cyano 4 4 17 alpha trimethyl androst 5 one 17 beta ol 3 one cyano ketone 2 hydroxy methylene androstan 17 beta ol 3 one hydroxy methylene estradiol 17 beta medroxyprogesterone 1 2 alpha methylene 6 chloro pregn 4 6 dien 17 alpha ol 3 20 dione cyproterone 17 beta hydroxy 4 4 17 alpha trimethyl a. Journal of Clinical Endocrinology & Metabolism 28(11): 1539-1546, 1968

Sts 557 17 alpha cyano methyl 17 beta hydroxy 13 beta methyl gona 4 9 dien 3 one. Drugs of the Future 5(6): 311-312, 1980